An Alternative Source for Allogeneic CAR T Cells With a High Safety Profile
Xiaolong Wu1,2, Ingo G H Schmidt-Wolf2
1Clinical Trial Center, National Medical Products Administration Key Laboratory for Clinical Research and Evaluation of Innovative Drugs, West China Hospital, Sichuan University, Chengdu, China.
Frontiers in Immunology
|June 9, 2022
Abstract
No abstract available in PubMed .


